Abstract
Session presented on: Tuesday, July 23, 2013:
Purpose: This study has dual, complementing purposes: first, a comprehensive literature review of reported gender, race, age and menopausal status variables in the treatment of hypertension in women, and second, an evaluation of hypertension treatment for best practices. These data were then compiled and utilized to propose a gender specific protocol for treatment of hypertension.
Method: A retrospective chart review of 100 women with the diagnosis of benign hypertension was performed in a large cardiovascular practice. Patient charts were reviewed to identify the antihypertensive medications currently in use, and the data were compared for best practices by using the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure (JNC 7) (Chobanian, 2003), and The Effectiveness-Based Guidelines for the Prevention of Cardiovascular Disease in Women 2011 Update (Mosca, 2011).
Results: When evaluating the evidence for best practices, these data show that out of the 100 women, 76% were found to have controlled hypertension (BP < 140/90), as compared to the national rate of 64% (CDC, 2005). The most common medications used in this practice were Beta Blockers, ACE Inhibitors, Angiotensin II Receptor Blockers, Calcium Channel Blockers, Alpha Blockers and Diuretics. Out of the 33 women who had the diagnosis of diabetes mellitus (DM), 54% were on an angiotensin converting enzyme inhibitor (ACE) or angiotensin receptor blocker (ARB), as recommended by JNC 7(Chobanian, 2003). Gender specific protocols were developed using these data as well as the research material.
Conclusion: The protocols developed are gender specific, with recommendations for the variables of age, race, menopausal status, and presence of co-morbidities. These protocols could easily streamline a treatment plan for new practitioners and also give women a voice in what current evidence shows is best practice in the treatment of hypertension.
Sigma Membership
Lambda Theta
Type
Presentation
Format Type
Text-based Document
Study Design/Type
N/A
Research Approach
N/A
Keywords:
Hypertension, Protocols, Women
Recommended Citation
Whiffen, Rebecca J., "Women are different!: Gender specific protocols for treatment of hypertension" (2013). INRC (Congress). 28.
https://www.sigmarepository.org/inrc/2013/presentations_2013/28
Conference Name
24th International Nursing Research Congress
Conference Host
Sigma Theta Tau International
Conference Location
Prague, Czech Republic
Conference Year
2013
Rights Holder
All rights reserved by the author(s) and/or publisher(s) listed in this item record unless relinquished in whole or part by a rights notation or a Creative Commons License present in this item record.
All permission requests should be directed accordingly and not to the Sigma Repository.
All submitting authors or publishers have affirmed that when using material in their work where they do not own copyright, they have obtained permission of the copyright holder prior to submission and the rights holder has been acknowledged as necessary.
Acquisition
Proxy-submission
Women are different!: Gender specific protocols for treatment of hypertension
Prague, Czech Republic
Session presented on: Tuesday, July 23, 2013:
Purpose: This study has dual, complementing purposes: first, a comprehensive literature review of reported gender, race, age and menopausal status variables in the treatment of hypertension in women, and second, an evaluation of hypertension treatment for best practices. These data were then compiled and utilized to propose a gender specific protocol for treatment of hypertension.
Method: A retrospective chart review of 100 women with the diagnosis of benign hypertension was performed in a large cardiovascular practice. Patient charts were reviewed to identify the antihypertensive medications currently in use, and the data were compared for best practices by using the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure (JNC 7) (Chobanian, 2003), and The Effectiveness-Based Guidelines for the Prevention of Cardiovascular Disease in Women 2011 Update (Mosca, 2011).
Results: When evaluating the evidence for best practices, these data show that out of the 100 women, 76% were found to have controlled hypertension (BP < 140/90), as compared to the national rate of 64% (CDC, 2005). The most common medications used in this practice were Beta Blockers, ACE Inhibitors, Angiotensin II Receptor Blockers, Calcium Channel Blockers, Alpha Blockers and Diuretics. Out of the 33 women who had the diagnosis of diabetes mellitus (DM), 54% were on an angiotensin converting enzyme inhibitor (ACE) or angiotensin receptor blocker (ARB), as recommended by JNC 7(Chobanian, 2003). Gender specific protocols were developed using these data as well as the research material.
Conclusion: The protocols developed are gender specific, with recommendations for the variables of age, race, menopausal status, and presence of co-morbidities. These protocols could easily streamline a treatment plan for new practitioners and also give women a voice in what current evidence shows is best practice in the treatment of hypertension.
